Australia's most trusted
source of pharma news
Sunday, 08 September 2024
Posted 26 July 2024 AM
Prota Therapeutics, a Melbourne based company focused on developing oral immunotherapy treatments against peanut allergy, has appointed Patrick Machado as Chair to its Board of Directors.
Machado has an impressive 30-year career in the biotechnology industry across North America and Europe.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.